Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

31.71
Delayed Data
As of Sep 27
 +0.70 / +2.26%
Today’s Change
20.07
Today|||52-Week Range
36.00
+12.09%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close31.01
Today’s open31.05
Day’s range30.84 - 31.74
Volume218,960
Average volume (3 months)294,027
Market cap$1.0B
Dividend yield--
Data as of 09/27/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+57.14%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio132.1
Price/Sales11.37
Price/Book8.32

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc+0.60+2.13%
EGRXEagle Pharmaceutical...+3.54+5.35%
ACORAcorda Therapeutics ...-0.93-4.05%
FOLDAmicus Therapeutics ...+0.28+3.72%
Data as of 09/27/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Search for Jobs